Metal alloys for medical devices

• US 9,107,899 B2
• Filed: 10/05/2012
• Issued: 08/18/2015
• Est. Priority Date: 03/03/2005
• Status: Active Grant

• Current Assignee: Mirus LLC
• Original Assignee: Icon Medical Corp. (ICON Interventional Systems, Inc.)
• Inventors: Furst, Joseph G., Patel, Udayan, Buckman, Raymond
• Primary Examiner(s): ZISKA, SUZANNE E
• Application Number:
  US13/645,909
• Publication Number:
  US 20140099279A1
• Time in Patent Office: 1,047 Days
• US Class Current: 1/1
• CPC Class Codes: A61K 31/337 having four-membered rings, e.g. taxol
• CPC Class Codes: A61K 31/407 condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
• CPC Class Codes: A61K 31/436 the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
• CPC Class Codes: A61K 31/519 ortho- or peri-condensed with heterocyclic rings
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: A61P 35/00 Antineoplastic agents
• CPC Class Codes: A61P 37/06 Immunosuppressants, e.g. drugs for graft rejection
• CPC Class Codes: B32B 3/00 Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form
• CPC Class Codes: C22C 27/04 Alloys based on tungsten or molybdenum
• CPC Class Codes: C22C 30/00 Alloys containing less than 50% by weight of each constituent
• CPC Class Codes: Y10T 428/12993 Surface feature [e.g., rough, mirror]
• CPC Class Codes: Y10T 428/24355 Continuous and nonuniform or irregular surface on layer or component [e.g., roofing, etc.]

Abstract

A medical device that is at least partially formed of a novel metal alloy, which novel metal alloy improves the physical properties of the medical device.

Claims

1. A medical device that is at least partially formed of a metal alloy which improves the strength and ductility of the medical device, said metal alloy including at least about 90 weight percent of a solid solution of a rhenium and molybdenum alloy, said metal alloy including at least about 40 weight percent rhenium and at least about 40 weight percent molybdenum, said metal alloy having a controlled amount of nitrogen, oxygen and carbon so as to reduce micro-cracking in said metal alloy, a nitrogen content of said metal alloy less than a combined content of oxygen and carbon in said metal alloy, said metal alloy including an oxygen to nitrogen atomic ratio of at least about 1.2:

1, said metal alloy including a carbon to nitrogen atomic ratio of at least about 2;

1.

2. The medical device as defined in claim 1, wherein said metal alloy includes less than about 0.2 weight percent carbon, less than about 0.1 weight percent oxygen, and less than about 0.001 weight percent nitrogen.

3. The medical device as defined in claim 1, wherein said metal alloy has a carbon to oxygen atomic ratio of about 0.2-2:

1.

4. The medical device as defined in claim 2, wherein said metal alloy has a carbon to oxygen atomic ratio of about 0.2-2:

1.

5. The medical device as defined in claim 1, wherein said metal alloy includes at least about 99 weight percent of a solid solution, said solid solution including at least 95 weight percent rhenium and molybdenum and less than about 5 weight percent of a metal selected from the group consisting of titanium, yttrium, zirconium, or mixtures thereof.

6. The medical device as defined in claim 4, wherein said metal alloy includes at least about 99 weight percent of a solid solution, said solid solution including at least 95 weight percent rhenium and molybdenum and less than about 5 weight percent of a metal selected from the group consisting of titanium, yttrium, zirconium, or mixtures thereof.

7. The medical device as defined in claim 1, wherein said metal alloy having an average yield strength of at least about 70 ksi and an average ultimate tensile strength of at least about 60 ksi, said metal alloy having an average grain size is about 5.2-10 ASTM, said metal alloy having an average tensile elongation of at least about 25%, said metal alloy having an average hardness of at least about 60 (HRC) at 77°

F., and said metal alloy having an average density of at least about 13.4 gm/cc.

8. The medical device as defined in claim 6, wherein said metal alloy having an average yield strength of at least about 70 ksi and an average ultimate tensile strength of at least about 60 ksi, said metal alloy having an average grain size is about 5.2-10 ASTM, said metal alloy having an average tensile elongation of at least about 25%, said metal alloy having an average hardness of at least about 60 (HRC) at 77°

F., and said metal alloy having an average density of at least about 13.4 gm/cc.

9. The medical device as defined in claim 1, wherein said metal alloy metal alloy includes a plurality of second phase particles, said second phase particles including one or more particles selected from the group consisting of carbides, carbo-nitrides, and oxides.

10. The medical device as defined in claim 8, wherein said metal alloy metal alloy includes a plurality of second phase particles, said second phase particles including one or more particles selected from the group consisting of carbides, carbo-nitrides, and oxides.

11. The medical device as defined in claim 1, wherein said metal alloy having a nitrogen content of less than about 0.001 weight percent, said metal alloy having a carbon content of less than about 0.2 weight percent, having an oxygen content of less than about 0.1 weight percent, said metal alloy including an oxygen to carbon atomic ratio of about 0.2:

1 and up to about 50;

1, said metal alloy including an oxygen to nitrogen atomic ratio of at least about 1.2;

1 and up to about 100;

1, said metal alloy including a carbon to nitrogen atomic ratio of at least about 2;

1 and up to about 100;

1.

12. The medical device as defined in claim 10, wherein said metal alloy having a nitrogen content of less than about 0.001 weight percent, said metal alloy having a carbon content of less than about 0.2 weight percent, having an oxygen content of less than about 0.1 weight percent, said metal alloy including an oxygen to carbon atomic ratio of about 0.2:

1 and up to about 50;

1, said metal alloy including an oxygen to nitrogen atomic ratio of at least about 1.2;

1 and up to about 100;

1, said metal alloy including a carbon to nitrogen atomic ratio of at least about 2;

1 and up to about 100;

1.

13. The medical device as defined in claim 1, wherein said metal alloy includes about 45-50 weight percent rhenium and about 50-55 weight percent molybdenum.

14. The medical device as defined in claim 12, wherein said metal alloy includes about 45-50 weight percent rhenium and about 50-55 weight percent molybdenum.

15. The medical device as defined in claim 1, wherein at least one region of said medical device includes at least one biological agent.

16. The medical device as defined in claim 14, wherein at least one region of said medical device includes at least one biological agent.

17. The medical device as defined in claim 15, wherein said at least one biologocal agent includes trapidil, trapidil derivatives, taxol, taxol derivatives, cytochalasin, cytochalasin derivatives, paclitaxel, paclitaxel derivatives, rapamycin, rapamycin derivatives, GM-CSF, GM-CSF derivatives, or combinations thereof.

18. The medical device as defined in claim 1, wherein at least one region of said medical device includes at least one polymer.

19. The medical device as defined in claim 16, wherein at least one region of said medical device includes at least one polymer, said at least one polymer at least partially coats, encapsulates or combinations thereof said at least one agent.

20. The medical device as defined in claim 18, wherein said at least one polymer includes parylene, a parylene derivative, chitosan, a chitosan derivative, PLGA, a PLGA derivative, PLA, a PLA derivative, PEVA, a PEVA derivative, PBMA, a PBMA derivative, POE, a POE derivative, PGA, a PGA derivative, PLLA, a PLLA derivative, PAA, a PAA derivative, PEG, a PEG derivative, or combinations thereof.

21. The medical device as defined in claim 1, wherein said medical device includes at least one micro-structure in an outer surface of said medical device.

22. The medical device as defined in claim 14, wherein said medical device includes at least one micro-structure in an outer surface of said medical device.

23. The medical device as defined in claim 16, wherein said medical device includes at least one micro-structure in an outer surface of said medical device.

24. The medical device as defined in claim 20, wherein said medical device includes at least one micro-structure in an outer surface of said medical device.

25. The medical device as defined in claim 21, wherein said at least one micro-structure is at least partially formed of, includes, or combinations thereof, a material consisting of a polymer, an agent, or combinations thereof.

26. The medical device as defined in claim 5, wherein said metal alloy includes at least 0.05 weight percent titanium and up to about 1 weight percent titanium.

27. The medical device as defined in claim 5, wherein said metal alloy includes at least 0.05 weight percent zirconium and up to about 0.5 weight percent zirconium.

28. The medical device as defined in claim 5, wherein said metal alloy includes at least 0.05 weight percent zirconium and up to about 0.5 weight percent zirconium, a weight ratio of titanium to zirconium in said metal alloy is about 1-10:

1.

29. The medical device as defined in claim 5, wherein said metal alloy includes at least 0.01 weight percent yttrium and up to about 0.3 weight percent yttrium.